SCHEMBL3362199

SCHEMBL3362199

CC1(C)OB(c2cccc(-c3ccccc3)c2)OC1(C)C

nearest known ligand 0.70

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 12/20 0.70
LPL P06858 11/20 0.70
P4HB P07237 1/20 0.40
DGAT1 O75907 1/20 0.38
IRAK4 Q9NWZ3 1/20 0.38
PDGFRB P09619 1/20 0.37
KDR P35968 1/20 0.37
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
MAOA P21397 1/20 0.36
ROCK1 Q13464 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29634298 1.00 LIPG (0.70) LIPGLPLP4HBDGAT1IRAK4
SCHEMBL30065945 0.98 LIPG (0.73) LIPGLPLP4HBDGAT1IRAK4
SCHEMBL30499382 0.98 LIPG (0.68) LIPGLPLP4HBDGAT1IRAK4
SCHEMBL30733252 0.98 LIPG (0.68) LIPGLPLP4HBDGAT1IRAK4
SCHEMBL15298699 0.98 LIPG (0.68) LIPGLPLP4HBDGAT1IRAK4
SCHEMBL13700830 0.98 LIPG (0.73) LIPGLPLP4HBDGAT1IRAK4
SCHEMBL29828851 0.98 LIPG (0.68) LIPGLPLP4HBDGAT1IRAK4
SCHEMBL15197437 0.98 LIPG (0.73) LIPGLPLP4HBDGAT1IRAK4
SCHEMBL17166641 0.98 LIPG (0.68) LIPGLPLP4HBDGAT1IRAK4
SCHEMBL12715039 0.98 LIPG (0.68) LIPGLPLP4HBDGAT1IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260055127-A1 METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENCE DEVICES UDC IRELAND LTD (IE) 2026-02-26 US disclosed
US-12454542-B2 Metal complexes for use as emitters in organic electroluminescence devices UDC IRELAND LIMITED (IE) 2025-10-28 US disclosed
US-20240300989-A1 METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENCE DEVICES UDC IRELAND LTD (IE) 2024-09-12 US disclosed
CN-117858600-A Condensed-cyclic compound, and light-emitting device, electronic device, and electronic apparatus including the same 三星显示有限公司 2024-04-09 CN disclosed
US-11932659-B2 Metal complexes for use as emitters in organic electroluminescence devices UDC IRELAND LIMITED (IE) 2024-03-19 US disclosed
US-11917901-B2 Metal complexes UDC IRELAND LIMITED (IE) 2024-02-27 US disclosed
US-11917901-B2 Metal complexes UDC IRELAND LIMITED (IE) 2024-02-27 US disclosed
US-20230363269-A1 ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-09 US disclosed
US-20230357150-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-11-09 US disclosed
CN-116987124-A Metal complexes as luminophores in organic electroluminescent devices 默克专利有限公司 2023-11-03 CN disclosed
WO-2014023377-A2 METAL COMPLEXES MERCK PATENT GMBH (DE) 2014-02-13 WO disclosed
WO-2014008982-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2014-01-16 WO disclosed
US-20130105786-A1 NOVEL SPIRO(ANTHRACENE-9,9'-FLUOREN)-10-ONE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-05-02 US disclosed
US-20130105786-A1 NOVEL SPIRO(ANTHRACENE-9,9'-FLUOREN)-10-ONE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-05-02 US disclosed
WO-2012008557-A1 NOVEL SPIRO (ANTHRACENE-9,9'-FLUOREN) -10-ONE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2012-01-19 WO disclosed
US-7745988-B2 3, 6-diphenylcarbazole compound and organic electroluminescent device RICOH COMPANY, LIMITED (JP) 2010-06-29 US disclosed
EP-1385524-A4 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2006-02-01 EP disclosed
US-20050084711-A1 3, 6-Diphenylcarbazole compound and organic electroluminescent device RICOH COMPANY LIMITED (JP) 2005-04-21 US disclosed
EP-1385524-A1 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS Abbott GmbH & Co. KG (DE) 2004-02-04 EP disclosed
WO-2002080926-A1 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO. KG (DE) 2002-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050084711-A1 3, 6-Diphenylcarbazole compound and organic electroluminescent device OXA1L, MCU, SLC25A21 LIPG 3462/4885LPL 1865/4885P4HB 1068/4885
US-12454542-B2 Metal complexes for use as emitters in organic electroluminescence devices ICMT, ORAI2, AOC2 LIPG 4819/4885LPL 4753/4885P4HB 3265/4885
US-20240300989-A1 METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENCE DEVICES ICMT, ORAI2, AOC2 LIPG 4819/4885LPL 4753/4885P4HB 3265/4885
US-11932659-B2 Metal complexes for use as emitters in organic electroluminescence devices MCU, AP3M1, AP2M1 LIPG 3307/4885LPL 3527/4885P4HB 3433/4885
US-20230357150-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE AOX1, CRY1, CYP1A1 LIPG 2610/4885LPL 2207/4885P4HB 1736/4885
US-20230363269-A1 ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME CYBA, CRY1, CRY2 LIPG 4538/4885LPL 4636/4885P4HB 1734/4885
US-20260055127-A1 METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENCE DEVICES SCO2, ROS1, MT-CO1 LIPG 4604/4885LPL 4678/4885P4HB 2926/4885
US-11917901-B2 Metal complexes MCOLN2, MCOLN1, AP1M1 LIPG 2895/4885LPL 2338/4885P4HB 2771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.